Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Iron supplements are available in two forms: oral and intravenous. Intravenous iron preparations are superior to oral supplements, as these lead to higher and faster increase in iron and Hb levels. Oral supplements have disadvantages such as GI adverse events, poor adherence, poor gastrointestinal absorption, and non-compliance.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Intraveno(IV) Iron Drugs market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Intraveno(IV) Iron Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Intraveno(IV) Iron Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Galenica
Pharmacosmos
Luitpold Pharmaceuticals
Actavis
Allergan
American Regent
Fresenius Medical Care
Sanofi
Vifor Pharma
AMAG Pharmaceuticals
By Type:
Low Molecular Weight Iron Dextran
Ferric Gluconate
Iron Sucrose
Ferric Carboxyl Maltose
By End-User:
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Intraveno(IV) Iron Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 USA Intraveno(IV) Iron Drugs Market Size and Growth Rate of Low Molecular Weight Iron Dextran from 2016 to 2027
-
1.3.2 USA Intraveno(IV) Iron Drugs Market Size and Growth Rate of Ferric Gluconate from 2016 to 2027
-
1.3.3 USA Intraveno(IV) Iron Drugs Market Size and Growth Rate of Iron Sucrose from 2016 to 2027
-
1.3.4 USA Intraveno(IV) Iron Drugs Market Size and Growth Rate of Ferric Carboxyl Maltose from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Intraveno(IV) Iron Drugs Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 USA Intraveno(IV) Iron Drugs Market Size and Growth Rate of Ambulatory Surgical Centers from 2016 to 2027
-
1.4.3 USA Intraveno(IV) Iron Drugs Market Size and Growth Rate of Diagnostic Centers from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Intraveno(IV) Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Intraveno(IV) Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Intraveno(IV) Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Intraveno(IV) Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Intraveno(IV) Iron Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Intraveno(IV) Iron Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of Low Molecular Weight Iron Dextran
-
3.4.2 Market Size and Growth Rate of Ferric Gluconate
-
3.4.3 Market Size and Growth Rate of Iron Sucrose
-
3.4.4 Market Size and Growth Rate of Ferric Carboxyl Maltose
4 Segmentation of Intraveno(IV) Iron Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Intraveno(IV) Iron Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Intraveno(IV) Iron Drugs in Hospitals
-
4.4.2 Market Size and Growth Rate of Intraveno(IV) Iron Drugs in Ambulatory Surgical Centers
-
4.4.3 Market Size and Growth Rate of Intraveno(IV) Iron Drugs in Diagnostic Centers
5 Market Analysis by Regions
-
5.1 USA Intraveno(IV) Iron Drugs Production Analysis by Regions
-
5.2 USA Intraveno(IV) Iron Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Intraveno(IV) Iron Drugs Landscape Analysis
-
6.1 West USA Intraveno(IV) Iron Drugs Landscape Analysis by Major Types
-
6.2 West USA Intraveno(IV) Iron Drugs Landscape Analysis by Major End-Users
7 South USA Intraveno(IV) Iron Drugs Landscape Analysis
-
7.1 South USA Intraveno(IV) Iron Drugs Landscape Analysis by Major Types
-
7.2 South USA Intraveno(IV) Iron Drugs Landscape Analysis by Major End-Users
8 Middle West USA Intraveno(IV) Iron Drugs Landscape Analysis
-
8.1 Middle West USA Intraveno(IV) Iron Drugs Landscape Analysis by Major Types
-
8.2 Middle West USA Intraveno(IV) Iron Drugs Landscape Analysis by Major End-Users
9 Northeast USA Intraveno(IV) Iron Drugs Landscape Analysis
-
9.1 Northeast USA Intraveno(IV) Iron Drugs Landscape Analysis by Major Types
-
9.2 Northeast USA Intraveno(IV) Iron Drugs Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Galenica
-
10.1.1 Galenica Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Pharmacosmos
-
10.2.1 Pharmacosmos Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Luitpold Pharmaceuticals
-
10.3.1 Luitpold Pharmaceuticals Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Actavis
-
10.4.1 Actavis Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Allergan
-
10.5.1 Allergan Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 American Regent
-
10.6.1 American Regent Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Fresenius Medical Care
-
10.7.1 Fresenius Medical Care Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Sanofi
-
10.8.1 Sanofi Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Vifor Pharma
-
10.9.1 Vifor Pharma Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 AMAG Pharmaceuticals
-
10.10.1 AMAG Pharmaceuticals Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Intraveno(IV) Iron Drugs Market Size and Growth Rate of Low Molecular Weight Iron Dextran from 2016 to 2027
-
Figure USA Intraveno(IV) Iron Drugs Market Size and Growth Rate of Ferric Gluconate from 2016 to 2027
-
Figure USA Intraveno(IV) Iron Drugs Market Size and Growth Rate of Iron Sucrose from 2016 to 2027
-
Figure USA Intraveno(IV) Iron Drugs Market Size and Growth Rate of Ferric Carboxyl Maltose from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Intraveno(IV) Iron Drugs Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure USA Intraveno(IV) Iron Drugs Market Size and Growth Rate of Ambulatory Surgical Centers from 2016 to 2027
-
Figure USA Intraveno(IV) Iron Drugs Market Size and Growth Rate of Diagnostic Centers from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Intraveno(IV) Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Intraveno(IV) Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Intraveno(IV) Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Intraveno(IV) Iron Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Intraveno(IV) Iron Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Intraveno(IV) Iron Drugs
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Intraveno(IV) Iron Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Intraveno(IV) Iron Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Low Molecular Weight Iron Dextran
-
Figure Market Size and Growth Rate of Ferric Gluconate
-
Figure Market Size and Growth Rate of Iron Sucrose
-
Figure Market Size and Growth Rate of Ferric Carboxyl Maltose
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Intraveno(IV) Iron Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Intraveno(IV) Iron Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Ambulatory Surgical Centers
-
Figure Market Size and Growth Rate of Diagnostic Centers
-
Table USA Intraveno(IV) Iron Drugs Production by Regions
-
Table USA Intraveno(IV) Iron Drugs Production Share by Regions
-
Figure USA Intraveno(IV) Iron Drugs Production Share by Regions in 2016
-
Figure USA Intraveno(IV) Iron Drugs Production Share by Regions in 2021
-
Figure USA Intraveno(IV) Iron Drugs Production Share by Regions in 2027
-
Table USA Intraveno(IV) Iron Drugs Consumption by Regions
-
Table USA Intraveno(IV) Iron Drugs Consumption Share by Regions
-
Figure USA Intraveno(IV) Iron Drugs Consumption Share by Regions in 2016
-
Figure USA Intraveno(IV) Iron Drugs Consumption Share by Regions in 2021
-
Figure USA Intraveno(IV) Iron Drugs Consumption Share by Regions in 2027
-
Table West USA Intraveno(IV) Iron Drugs Consumption by Types from 2016 to 2027
-
Table West USA Intraveno(IV) Iron Drugs Consumption Share by Types from 2016 to 2027
-
Figure West USA Intraveno(IV) Iron Drugs Consumption Share by Types in 2016
-
Figure West USA Intraveno(IV) Iron Drugs Consumption Share by Types in 2021
-
Figure West USA Intraveno(IV) Iron Drugs Consumption Share by Types in 2027
-
Table West USA Intraveno(IV) Iron Drugs Consumption by End-Users from 2016 to 2027
-
Table West USA Intraveno(IV) Iron Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2016
-
Figure West USA Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2021
-
Figure West USA Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2027
-
Table South USA Intraveno(IV) Iron Drugs Consumption by Types from 2016 to 2027
-
Table South USA Intraveno(IV) Iron Drugs Consumption Share by Types from 2016 to 2027
-
Figure South USA Intraveno(IV) Iron Drugs Consumption Share by Types in 2016
-
Figure South USA Intraveno(IV) Iron Drugs Consumption Share by Types in 2021
-
Figure South USA Intraveno(IV) Iron Drugs Consumption Share by Types in 2027
-
Table South USA Intraveno(IV) Iron Drugs Consumption by End-Users from 2016 to 2027
-
Table South USA Intraveno(IV) Iron Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2016
-
Figure South USA Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2021
-
Figure South USA Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2027
-
Table Middle West USA Intraveno(IV) Iron Drugs Consumption by Types from 2016 to 2027
-
Table Middle West USA Intraveno(IV) Iron Drugs Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Intraveno(IV) Iron Drugs Consumption Share by Types in 2016
-
Figure Middle West USA Intraveno(IV) Iron Drugs Consumption Share by Types in 2021
-
Figure Middle West USA Intraveno(IV) Iron Drugs Consumption Share by Types in 2027
-
Table Middle West USA Intraveno(IV) Iron Drugs Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Intraveno(IV) Iron Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2016
-
Figure Middle West USA Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2021
-
Figure Middle West USA Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2027
-
Table Northeast USA Intraveno(IV) Iron Drugs Consumption by Types from 2016 to 2027
-
Table Northeast USA Intraveno(IV) Iron Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Intraveno(IV) Iron Drugs Consumption Share by Types in 2016
-
Figure Northeast USA Intraveno(IV) Iron Drugs Consumption Share by Types in 2021
-
Figure Northeast USA Intraveno(IV) Iron Drugs Consumption Share by Types in 2027
-
Table Northeast USA Intraveno(IV) Iron Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Intraveno(IV) Iron Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2016
-
Figure Northeast USA Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2021
-
Figure Northeast USA Intraveno(IV) Iron Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Galenica
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Galenica
-
Figure Sales and Growth Rate Analysis of Galenica
-
Figure Revenue and Market Share Analysis of Galenica
-
Table Product and Service Introduction of Galenica
-
Table Company Profile and Development Status of Pharmacosmos
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pharmacosmos
-
Figure Sales and Growth Rate Analysis of Pharmacosmos
-
Figure Revenue and Market Share Analysis of Pharmacosmos
-
Table Product and Service Introduction of Pharmacosmos
-
Table Company Profile and Development Status of Luitpold Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Luitpold Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Luitpold Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Luitpold Pharmaceuticals
-
Table Product and Service Introduction of Luitpold Pharmaceuticals
-
Table Company Profile and Development Status of Actavis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actavis
-
Figure Sales and Growth Rate Analysis of Actavis
-
Figure Revenue and Market Share Analysis of Actavis
-
Table Product and Service Introduction of Actavis
-
Table Company Profile and Development Status of Allergan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan
-
Figure Sales and Growth Rate Analysis of Allergan
-
Figure Revenue and Market Share Analysis of Allergan
-
Table Product and Service Introduction of Allergan
-
Table Company Profile and Development Status of American Regent
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of American Regent
-
Figure Sales and Growth Rate Analysis of American Regent
-
Figure Revenue and Market Share Analysis of American Regent
-
Table Product and Service Introduction of American Regent
-
Table Company Profile and Development Status of Fresenius Medical Care
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fresenius Medical Care
-
Figure Sales and Growth Rate Analysis of Fresenius Medical Care
-
Figure Revenue and Market Share Analysis of Fresenius Medical Care
-
Table Product and Service Introduction of Fresenius Medical Care
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Vifor Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vifor Pharma
-
Figure Sales and Growth Rate Analysis of Vifor Pharma
-
Figure Revenue and Market Share Analysis of Vifor Pharma
-
Table Product and Service Introduction of Vifor Pharma
-
Table Company Profile and Development Status of AMAG Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AMAG Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of AMAG Pharmaceuticals
-
Figure Revenue and Market Share Analysis of AMAG Pharmaceuticals
-
Table Product and Service Introduction of AMAG Pharmaceuticals
-
